InvestorsHub Logo

justdafactss

03/23/23 12:33 PM

#218798 RE: The Dark KnaDDir #218796

YUP! I dont see how the co and BOD is innocent or can play dumb in all of this---

VANCOUVER, Washington, April 27, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, today announced the Company has submitted the clinical, and the CMC (chemistry, manufacturing and controls) portions of its BLA to the U.S. Food and Drug Administration (FDA) for leronlimab as a combination therapy with HAART for highly treatment experienced HIV patients. The FDA previously granted both Fast Track designation for leronlimab and rolling review for the Company’s BLA in HIV indication.

“The submission of the final two parts of the BLA is a significant milestone for the Company, and initiates its transition from a development-stage company to a commercial organization.
https://www.globenewswire.com/news-release/2020/04/27/2022519/0/en/CytoDyn-Submits-Completed-Biologics-License-Application-BLA-to-the-FDA-for-Leronlimab-as-a-Combination-Therapy-for-Highly-Treatment-Experienced-HIV-Patients.html